PuSH - Publikationsserver des Helmholtz Zentrums München

New technologies for developing phage-based tools to manipulate the human microbiome.

Trends Microbiol. 30, 131-142 (2022)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Gut bacteria play an essential role in the human body by regulating multiple functions, producing essential metabolites, protecting against pathogen invasion, and much more. Conversely, changes in their community structure are linked to several gastrointestinal (GI) and non-GI conditions. Fortunately, these bacteria are amenable to external perturbations, but we need specific tools for their safe manipulation as nonspecific changes can cause unpredicted long-term consequences. Here, we mainly discuss recent advances in cultivation-independent technologies and argue their relevance to different key steps, that is, identifying the modulation targets and developing phage-based tools to precisely modulate gut bacteria and restore a sustainable microbiome in humans. We finally suggest multiple modulating strategies for different dysbiosis-associated diseases.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
18.230
3.727
6
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Cultivation-independent Technologies ; Microbiome Manipulation ; Multi-omics ; Phages ; Viral-tagging; Human Gut; Host-range; Bacteria; Metabolism; Bacteriophages; Cultivation; Resistance; Therapy; Patient
Sprache englisch
Veröffentlichungsjahr 2022
Prepublished im Jahr 2021
HGF-Berichtsjahr 2021
ISSN (print) / ISBN 0966-842X
e-ISSN 1878-4380
Quellenangaben Band: 30, Heft: 2, Seiten: 131-142 Artikelnummer: , Supplement: ,
Verlag Cell Press
Verlagsort Cambridge, Mass.
Begutachtungsstatus Peer reviewed
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-554300-001
Förderungen German Research Foundation (DFG Emmy Noether program)
European Research Council
Scopus ID 85106296780
PubMed ID 34016512
Erfassungsdatum 2021-06-18